Exact Mass: 294.2096

Exact Mass Matches: 294.2096

Found 41 metabolites which its exact mass value is equals to given mass value 294.2096, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

trimipramine

trimipramine

C20H26N2 (294.2096)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; EAWAG_UCHEM_ID 2861

   

Trimipramine

(3-{2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}-2-methylpropyl)dimethylamine

C20H26N2 (294.2096)


Trimipramine is only found in individuals that have used or taken this drug. It is a tricyclic antidepressant similar to imipramine, but with more antihistaminic and sedative properties. [PubChem]Trimipramines mechanism of action differs from other tricyclic antidepressants. Trimipramine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT). N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

1,4-Diphenethylpiperazine

1,4-bis(2-phenylethyl)piperazine

C20H26N2 (294.2096)


   

Dimetacrine

[3-(9,9-dimethyl-9,10-dihydroacridin-10-yl)propyl]dimethylamine

C20H26N2 (294.2096)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

(+)-(2S,5S)-2,5-dibenzyl-1,4-dimethylpiperazine|(2S,5S)-1,4-dimethyl-2,5-bis(phenylmethyl)piperazine|(2S,5S)-2,5-dibenzyl-1,4-dimethylpiperazine|2,5-Dibenzylpiperazine-N,N-Di-Me

(+)-(2S,5S)-2,5-dibenzyl-1,4-dimethylpiperazine|(2S,5S)-1,4-dimethyl-2,5-bis(phenylmethyl)piperazine|(2S,5S)-2,5-dibenzyl-1,4-dimethylpiperazine|2,5-Dibenzylpiperazine-N,N-Di-Me

C20H26N2 (294.2096)


   

N1-Methylaspidofractinine

N1-Methylaspidofractinine

C20H26N2 (294.2096)


   

ent-N(1)-methyl-14,15-didehydroaspidospermidine|N(a)-Acetyl-6,7-dehydro-aspidospermidin

ent-N(1)-methyl-14,15-didehydroaspidospermidine|N(a)-Acetyl-6,7-dehydro-aspidospermidin

C20H26N2 (294.2096)


   

Aristomakine

Aristomakine

C20H26N2 (294.2096)


   

epi-3 aristoserratenine

epi-3 aristoserratenine

C20H26N2 (294.2096)


   

Alloaristoteline

Alloaristoteline

C20H26N2 (294.2096)


   

(-)-16R,21R-O-Methyleburnamine

(-)-16R,21R-O-Methyleburnamine

C20H26N2 (294.2096)


   

Aristoserratenine

Aristoserratenine

C20H26N2 (294.2096)


   

(+)-(3R,5R,15S,20R)-5-methylyohimbane|Yohambinine

(+)-(3R,5R,15S,20R)-5-methylyohimbane|Yohambinine

C20H26N2 (294.2096)


   

(+)-Hobartine

(+)-Hobartine

C20H26N2 (294.2096)


   
   
   

Aristoteline

Aristoteline

C20H26N2 (294.2096)


   

N-benzyl-N-(2-phenylethyl)piperidin-4-amine

N-benzyl-N-(2-phenylethyl)piperidin-4-amine

C20H26N2 (294.2096)


   

Yohimban, 1-methyl-(7CI,8CI,9CI)

Yohimban, 1-methyl-(7CI,8CI,9CI)

C20H26N2 (294.2096)


   

1,1-bis-(4-Amino-3-methylphenyl)cyclohexane

1,1-bis-(4-Amino-3-methylphenyl)cyclohexane

C20H26N2 (294.2096)


   

Dimetacrine

Dimetacrine

C20H26N2 (294.2096)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

8-Cyclohexyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino[3,2,1-jk]carbazole

8-Cyclohexyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino[3,2,1-jk]carbazole

C20H26N2 (294.2096)


   
   

(S)-tetrindole

(S)-tetrindole

C20H26N2 (294.2096)


   
   

(R)-tetrindole

(R)-tetrindole

C20H26N2 (294.2096)


   

(1s,12r,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraene

(1s,12r,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraene

C20H26N2 (294.2096)


   

(1'r,3r,4'r,7'r,11's)-4',9',9'-trimethyl-10'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,¹¹]undecane]

(1'r,3r,4'r,7'r,11's)-4',9',9'-trimethyl-10'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,¹¹]undecane]

C20H26N2 (294.2096)


   

(2s,5s)-2,5-dibenzyl-1,4-dimethylpiperazine

(2s,5s)-2,5-dibenzyl-1,4-dimethylpiperazine

C20H26N2 (294.2096)


   

3-{[(1s,2r,5s)-4,4-dimethyl-8-methylidene-3-azabicyclo[3.3.1]nonan-2-yl]methyl}-1h-indole

3-{[(1s,2r,5s)-4,4-dimethyl-8-methylidene-3-azabicyclo[3.3.1]nonan-2-yl]methyl}-1h-indole

C20H26N2 (294.2096)


   

1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraene

1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraene

C20H26N2 (294.2096)


   

3-{[(1s,2r,5s)-4,4,8-trimethyl-3-azabicyclo[3.3.1]non-7-en-2-yl]methyl}-1h-indole

3-{[(1s,2r,5s)-4,4,8-trimethyl-3-azabicyclo[3.3.1]non-7-en-2-yl]methyl}-1h-indole

C20H26N2 (294.2096)


   

2,5-dibenzyl-1,4-dimethylpiperazine

2,5-dibenzyl-1,4-dimethylpiperazine

C20H26N2 (294.2096)


   

n-isopropyl-11b-methyl-1h,2h,4ah,5h,6h,11h-cyclohexa[a]carbazol-5-amine

n-isopropyl-11b-methyl-1h,2h,4ah,5h,6h,11h-cyclohexa[a]carbazol-5-amine

C20H26N2 (294.2096)


   

(4as,5r,11br)-n-isopropyl-11b-methyl-1h,2h,4ah,5h,6h,11h-cyclohexa[a]carbazol-5-amine

(4as,5r,11br)-n-isopropyl-11b-methyl-1h,2h,4ah,5h,6h,11h-cyclohexa[a]carbazol-5-amine

C20H26N2 (294.2096)


   

4-methyl-10-(2-methylbut-3-en-2-yl)-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene

4-methyl-10-(2-methylbut-3-en-2-yl)-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene

C20H26N2 (294.2096)


   

3-({4,4-dimethyl-8-methylidene-3-azabicyclo[3.3.1]nonan-2-yl}methyl)-1h-indole

3-({4,4-dimethyl-8-methylidene-3-azabicyclo[3.3.1]nonan-2-yl}methyl)-1h-indole

C20H26N2 (294.2096)


   

(1r,12r,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraene

(1r,12r,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraene

C20H26N2 (294.2096)


   

4',9',9'-trimethyl-10'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,¹¹]undecane]

4',9',9'-trimethyl-10'-azaspiro[indole-3,3'-tricyclo[5.3.1.0⁴,¹¹]undecane]

C20H26N2 (294.2096)


   

4',10',10'-trimethyl-11'-azaspiro[indole-3,5'-tricyclo[5.2.2.0⁴,⁸]undecane]

4',10',10'-trimethyl-11'-azaspiro[indole-3,5'-tricyclo[5.2.2.0⁴,⁸]undecane]

C20H26N2 (294.2096)


   

12-methyl-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene

12-methyl-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene

C20H26N2 (294.2096)